Indeed, in some tumors a negative outcome correlates more closely with TIMP-2 than with MT1-MMP levels [28–35], and high TIMP-2 levels in primary breast carcinomas are associated with the development of distant metastases [30,36]. This evidence concerns the gene TIMP2 and breast carcinoma.